Literature DB >> 8963873

Theophylline in chronic asthma--evidence for disease-modifying properties.

K F Chung1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8963873     DOI： 10.1111/j.1365-2222.1996.tb01139.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  4 in total

1.  Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice.

Authors:  S Lim; A Jatakanon; D Gordon; C Macdonald; K F Chung; P J Barnes
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma.

Authors:  Chun-Hua Wang; Horng-Chyuan Lin; Chien-Huang Lin; Chih-Teng Yu; Su-Ling Liu; Kuo-Hsiung Huang; Kian Fan Chung; Han-Pin Kuo
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 3.  Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Authors:  M A Giembycz
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Drug treatment of asthma in the 1990s: achievements and new strategies.

Authors:  A Tavakkoli; P J Rees
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.